Chad Beyer
Senior Vice President of Research and Development
Promentis

Chad Beyer, PhD, MBA is Senior Vice President of Research and Development at Promentis. He has over 20 years of experience in the research, discovery and development of medications aimed to treat CNS and neurological disorders. Prior to joining Promentis, Dr. Beyer served as the Head of Neurochemistry and led the Psychiatry Task Force at Wyeth Pharmaceuticals in Princeton, NJ. During his career at Wyeth, Dr. Beyer led several early-stage drug discovery teams and managed a group responsible for contributing to the commercialization and life-cycle management of two blockbuster medications. Dr. Beyer holds a Ph.D. in Neuropharmacology from LSU Medical Center and an MBA from the Rutgers Business School. Notably, Dr. Beyer has authored more than 70 manuscripts, 3 patents, co-edited “Next Generation Antidepressants” and is co-founder of the journal “Technology Transfer & Entrepreneurship.” Dr. Beyer is also an adjunct faculty member at Thomas Jefferson University and Corporate Faculty member at Harrisburg University where he teaches “Bioventure Management”, a class focused on the business of doing science.